While Charles River Laboratories International Inc has underperformed by -2.97%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CRL fell by -9.52%, with highs and lows ranging from $230.02 to $91.86, whereas the simple moving average jumped by 7.81% in the last 200 days.
On October 06, 2025, William Blair Upgraded Charles River Laboratories International Inc (NYSE: CRL) to Outperform. A report published by Barclays on October 02, 2025, Upgraded its rating to ‘Overweight’ for CRL. Jefferies also Upgraded CRL shares as ‘Buy’, setting a target price of $195 on the company’s shares in a report dated September 09, 2025. Redburn Atlantic May 23, 2025d its ‘Neutral’ rating to ‘Buy’ for CRL, as published in its report on May 23, 2025. TD Cowen’s report from May 14, 2025 suggests a price prediction of $179 for CRL shares, giving the stock a ‘Buy’ rating. Evercore ISI also rated the stock as ‘Outperform’.
Analysis of Charles River Laboratories International Inc (CRL)
Further, the quarter-over-quarter increase in sales is 0.59%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Charles River Laboratories International Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -1.96% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.10, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and CRL is recording an average volume of 924.93K. On a monthly basis, the volatility of the stock is set at 3.48%, whereas on a weekly basis, it is put at 3.41%, with a loss of -5.81% over the past seven days. Furthermore, long-term investors anticipate a median target price of $182.21, showing growth from the present price of $167.03, which can serve as yet another indication of whether CRL is worth investing in or should be passed over.
How Do You Analyze Charles River Laboratories International Inc Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.12%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 102.93% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
